Patients with head and neck cancer were found to have plasma-derived exosomes that carried functional PD-L1, which was related to the clinicopathological characteristics of patients, rather than soluble PD-L1 (sPD-L1) (32). The gene discussed is CD274; the disease is head and neck cancer.